|
General References
Boston Women’s Health Book Collective. The
New Our Bodies, Ourselves — A Book by and for Women.
New York: Simon & Schuster, 1992.
Cates W. Contraception, unintended pregnancy and sexually transmitted
diseases: Why isn’t a simple solution possible? Am
J Epidemiol 1996; 143(4):311-18.
Cates W. Contraceptive choice, sexually transmitted diseases,
HIV infection and future fecundity. J
Br Fertil Soc 1996; 1(1):18-22.
Cates W, Stone KM. Family planning, sexually transmitted diseases
and contraceptive choice: A literature update — part I.
Fam Plann Perspect 1992; 24(2):75-84.
Centers for Disease Control and Prevention. Update: Barrier
protection against HIV infection and other sexually transmitted
diseases. MMWR 1993; 42:589-91,
597.
Centers for Disease Control. Family
Planning Methods and Practices: Africa. Atlanta, GA:
Centers for Disease Control, 1983.
Family Health International. Barrier methods. Network
1996; 16(3).
Feldblum P, Joanis C. Modern Barrier
Methods: Effective Contraception and Disease Prevention.
Durham, NC: Family Health International, 1994.
Hatcher RA, Trussell J, Stewart F, et al. (eds). Contraceptive
Technology 16th Revised Edition. New York: Irvington
Publishers Inc., 1994.
Jones E, Forrest JD. Contraceptive failure rates based on the
1988 NSFG. Fam Plann Perspect
1992; 24(1):12-19.
Mauck C, Cordero M, Gabelnick H, et al. (eds.). Barrier
Contraceptives: Current Status and Future Prospects.
New York: Wiley-Liss, 1994.
Program for International Training in Health (INTRAH). Guidelines
for Clinical Procedures in Family Planning — A Reference
for Trainers. Chapel Hill, NC: INTRAH, 1993.
Trussell J, Hatcher RA, Cates W Jr, et al. Contraceptive failure
in the United States: An update. Stud
Fam Plann 1990; 21:51-54.
World Health Organization. Improving
Access to Quality Care in Family Planning — Medical Eligibility
Criteria for Contraceptive Use. Geneva, Switzerland:
World Health Organization, 1996.
World Health Organization. Introduction
of New Contraceptives into Family Planning Programmes.
Geneva, Switzerland: World Health Organization, 1990.
Male Condoms
Kestelman P, Trussell J. Efficacy of the simultaneous use
of condoms and spermicides. Fam Plann
Perspect 1991; 23(5):226-32.
Liskin L, Wharton C, Blackburn R. Condoms—now more than
ever. Popul Rep 1990; H (8).
Oakley D, Bogue E-L. Quality of condom use as reported by female
clients of a family planning clinic. Am
J Public Health 1995; 85(11):1526-30.
Program for Appropriate Technology in Health (PATH). Condoms
protect against STDs and HIV: Correct and consistent use is
key. Outlook, 1994; 12(4).
Richters J, Donovan B, Gerofi J. How often do condoms break
or slip off in use? Int J STD AIDS
1993; 4:90-94.
Spruyt A, Steiner M, Joanis C, et al. Identifying condom users
at risk of breakage and slippage: Three international sites.
FHI unpublished paper, 1996.
Steiner M, Piedrahita C, Glover L, et al. Can condom users
likely to experience condom failure be identified? Fam
Plann Perspect 1993; 25(5):220-23, 226.
Steiner M, Piedrahita C, Joanis C, et al. Condom breakage and
slippage rates among study participants in eight countries.
Int Fam Plann Perspect 1994;
20(2):55-58.
Steiner M, Trussell J, Glover L, et al. Standardized protocols
for condom breakage and slippage trials: A proposal. Am
J Public Health 1994; 84(12):1897-1900.
Thapa S, Prasad CVS, Rao PH, et al. Social marketing of condoms
in India. Adv Popul 1994; 2:171-204.
Turjanmaa K, Reunala T. Condoms as a source of latex allergen
and cause of contact urticaria. Contact
Dermatitis 1989; 20:360-64.
World Health Organization. Guide to
Adapting Instructions on Condom Use. Geneva, Switzerland:
WHO Global Programme on AIDS, 1992.
Disease Prevention
Badiani R, de Oliveira MR, Pinto P, et al. Empowering
Women to Negotiate Safe Sex: A Model from Brazil. XXII
National Council for International Health, Washington D.C.,
June 1995.
Cates W, Holmes KK. Re: Condom efficacy against gonorrhea and
nongonococcal urethritis [letter]. Am
J Epidemiol 1996; 143(8): 843-44.
Centers for Disease Control and Prevention. Update: Barrier
protection against HIV infection and other sexually transmitted
diseases. MMWR 1993; 42:589-91,
597.
Daly CC, Helling-Giese GE, Mati JK, et al. Contraceptive methods
and the transmission of HIV: Implications for family planning.
Genitourin Med 1994; 70(2):110-17.
de Vincenzi I. A longitudinal study of human immunodeficiency
virus transmission by heterosexual partners. N
Engl J Med 1994; 331(6):341-46.
Feldblum PJ, Morrison CS, Roddy RE, et al. The effectiveness
of barrier methods of contraception in preventing the spread
of HIV. AIDS 1995; 9(suppl A):S85-S93.
Feldblum PJ, Weir SS. The protective effect of nonoxynol-9
against HIV infection [letter]. Am
J Public Health 1994; 84(6):1032-34.
Focus on spermicides: Controversy over HIV protection persists,
despite promising studies of nonoxynol-9. Contracept
Tech Update 1994; 15:13-18, 23.
Kassler WJ, Wasserheit JN, Cates W. Sexually transmitted diseases.
In: Woolf SH, Jonas S, Lawrence RS (eds). Health
Promotion and Disease Prevention in Clinical Practice.
(Baltimore: Williams & Wilkins, 1995), 273-90.
Dreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol-9
contraceptive sponge use in preventing heterosexual acquisition
of HIV in Nairobi prostitutes. JAMA
1992; 268:477-82.
Ngugi EN, Plummer FA, Simonsen JN, et al. Prevention of transmission
of human immunodeficiency virus in Africa: Effectiveness of
condom promotion and health education among prostitutes. Lancet
1988; II(8616): 887-90.
Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9
and reduction in rate of gonococcal and chlamydial infections.
Lancet 1992; 339:1371-75.
Roddy RE. Efficacy of nonoxynol-9 for preventing HIV transmission.
In: Senanayake P, Kleinman RL (eds). Family
planning: Meeting challenges, promoting choices. Proceedings
of the IPPF Family Planning Congress, New Delhi. (New
York: Parthenon, 1993), 543-45.
Rojanapithayakorn W, Hanenberg R. The 100 percent condom program
in Thailand. AIDS 1996; 10:1-7.
Rosenberg MJ, Davidson AJ, Chen J-H, et al. Barrier contraception
and sexually transmitted diseases in women: A comparison of
female-dependent methods and condoms. Am
J Public Health 1992; 82:669-74.
Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual
transmission of HIV: Longitudinal study of 343 steady partners
of infected men. J Acq Immune Defic
Syndr 1993; 6:497-502.
Steiner M, Joanis C. Acceptability of dual method use. Fam
Plann Perspect 1993; 25(5):234.
Weir SS, Feldblum PJ, Zekeng L, et al. The use of nonoxynol-9
for protection against cervical gonorrhea. Am
J Public Health 1994; 84:910-14.
Weisman CS, Plichta S, Nathanson CA, et al. Consistency of
condom use for disease prevention among adolescent users of
oral contraceptives. Fam Plann Perspect
1991; 23(2): 71-74.
Zekeng L, Feldblum PJ, Oliver RM, et al. Barrier contraceptive
use and HIV infection among high-risk women in Cameroon. AIDS
1003; 7:725-31.
Spermicides, Diaphragm, Cervical Cap
Bounds W, Guillebaud J, Dominik R, et al. The diaphragm with
and without spermicide: A randomized comparative efficacy trial.
J Reprod Med 1995; 40(11):764-74.
Cervical cap: Effective, convenient, but overlooked. Contracept
Tech Update 1990; 11:49-54.
Chalker R. The Complete Cervical Cap
Guide. New York: Harper & Row, 1987.
Hira S, Spruyt A, Feldblum PJ, et al. Spermicide acceptability
among patients at a sexually transmitted disease clinic in Zambia.
Am J Public Health 1995; 85(8):1098-1103.
Ferreira AE, Araujo MJ, Regina CH, et al. Effectiveness of
the diaphragm, used continuously, without spermicide. Contraception
1993; 48:29-35.
Program for Appropriate Technology in Health (PATH). Vaginal
barrier methods: Underutilized Option? Outlook
1993; 11(4).
Roddy RE, Cordero M, Cordero C, et al. A dosing study of nonoxynol-9
and genital irritation. Int J STD AIDS
1993; 4:165-70.
Rosenberg MJ, Davidson AJ, Chen J-H, et al. Barrier contraceptives
and sexually transmitted diseases in women: A comparison of
female-dependent methods and condoms. Am
J Public Health 1992; 82:669-674.
Smith C, Farr MG, Feldblum PJ, et al. Effectiveness of the
non-spermicidal fit-free diaphragm. Contraception
1995; 51(5):289-91.
Steiner M, Spruyt A, Joanis C, et al. Acceptability of spermicidal
film and foaming tablets among women in three countries.
Int Fam Plann Perspect 1995; 21(3):104-07.
The switch is on from foam to film. Contracept
Tech Update 1993; 14:169-71.
Trussell J, Strickler J, Vaughan B. Contraceptive efficacy
of the diaphragm, the sponge and the cervical cap. Fam
Plann Perspect 1993; 25:100-05, 135.
New Methods, Including Female Condom
Elias CJ, Heise LL. Challenges for the development of female-controlled
vaginal microbicides. AIDS 1994;
8:1-9.
Farr G, Gabelnick H, Sturgen K, et al. Contraceptive efficacy
and acceptability of the female condom. Am
J Public Health 1994; 84(12):1897-1900.
Mendez F, Castro A, Ortega A. Use effectiveness of a spermicidal
suppository containing benzalkonium chloride. Contraception
1986; 34:353-62.
Psychoyos A, Creatsas G, Hassan E, et al. Spermicidal and antiviral
properties of cholic acid: Contraceptive efficacy of a new vaginal
sponge (Protectaid) containing sodium cholate. Hum
Reprod 1993; 8:866-69.
Shihata AA, Trussell J. New female intravaginal barrier contraceptive
device: Preliminary clinical trial. Contraception
1991; 44:11-19.
Shihata AA, Gollub E. Acceptability of a new intravaginal barrier
contraceptive (Femcap). Contraception
1992; 46:511-19.
Soper DE, Brockwell NJ, Dalton HP. Evaluation of the effects
of a female condom on the female lower genital tract. Contraception
1991; 44:21-29.
Soper DE, Shoupe D, Shangold GA, et al. Prevention of vaginal
trichomoniasis by compliant use of the female condom. Sex
Transm Dis 1993; 20:137-39.
Stein ZA. Vaginal microbicides and prevention of HIV infection
[letter]. Lancet 1994; 343:362-63.
Trussell J, Sturgen K, Strickler J, et al. Comparative contraceptive
efficacy of the female condom and other barrier methods. Fam
Plann Perspect 1994; 26(2):66-72.
Wisconsin Pharmacal. Reality Female
Condom: A Monograph for Healthcare Professionals, Research Findings
and Usage Considerations. Chicago, IL: Wisconsin Pharmacal,
1994.
|
